American engineers deployed medical nanobots that clear arterial plaque and prevent heart attacks. The tiny machines, smaller than red blood cells, successfully cleared dangerous blockages in clinical trials at Johns Hopkins without damaging vessel walls.
These smart nanobots are programmed to seek out specific molecular signatures of dangerous plaque, then release enzymes that dissolve it while leaving healthy tissue untouched. They communicate with each other using chemical signals, working as a coordinated swarm before safely biodegrading. The entire procedure is minimally invasive, delivered through a simple IV.
Heart disease remains the leading cause of death globally. This technology could prevent millions of heart attacks and strokes annually. Patients in the trial showed dramatically improved blood flow and reduced inflammation markers within weeks.
The same platform is being adapted for cancer drug delivery and neurological repair. The age of programmable medicine at the cellular level has begun.
Source: Johns Hopkins University, Science Robotics 2026
Geen opmerkingen:
Een reactie posten